Actavis Pharmaceuticals buPROPion Hydrochloride Extended - Release Tablets (XL) 300 mg, 30 recall — FDA D-175-2013
Failed Dissolution Specifications; 8-hours for the 18-month stability testing point.
Overview of recall records associated with Actavis Pharmaceuticals, including dates, categories and classifications where available.
Classification mix: Class III: 1.
Failed Dissolution Specifications; 8-hours for the 18-month stability testing point.
This page summarizes recall records in which the official source identifies Actavis Pharmaceuticals as the recalling firm or manufacturer. The number of records should not be treated as a safety rating or a measure of company size, because recall counts depend on product mix, reporting periods and how government records are organized.
Compare the dates, categories and classifications together rather than relying on the total alone. Open an individual record for the recalled product, reason, distribution details and current instructions available from the source.